500124:BOM
Dr Reddy's Laboratories Ltd
1 231,85 ₹
arrow_upward
+0,91%(+11,10) 1K
16-okt, 15:59:49 (GMT+5:30) · INR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto500124 tikeri uchun statistika yaratilmoqda...
Ochish
1 227,10 ₹
Yuqori
1 231,85 ₹
Past
1 213,80 ₹
Bozor kapitali
1,02 trln
Oʻrtacha hajm
87,44 ming
Hajmi
77,54 ming
Dividend
0,65%
Choraklik dividendlar
2,00 ₹
Eks-dividend sanasi
10-iyl, 2026
P/E koeffitsiyenti
31,85
52 haftalik eng yuqori
1 414,40 ₹
52 haftalik eng past
1 080,05 ₹
Aksiya boʻyicha daromad
38,67 ₹
Muomaladagi aksiyalar
166,06 mln
Xodimlar soni
28 ming
Ochish
1 227,10 ₹
Yuqori
1 231,85 ₹
Past
1 213,80 ₹
Bozor kapitali
1,02 trln
Oʻrtacha hajm
87,44 ming
Hajmi
77,54 ming
Dividend
0,65%
Choraklik dividendlar
2,00 ₹
Eks-dividend sanasi
10-iyl, 2026
P/E koeffitsiyenti
31,85
52 haftalik eng yuqori
1 414,40 ₹
52 haftalik eng past
1 080,05 ₹
Aksiya boʻyicha daromad
38,67 ₹
Muomaladagi aksiyalar
166,06 mln
Xodimlar soni
28 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
MarketBeat
·
1 kun oldin
Dr. Reddy's Laboratories (NYSE:RDY) Stock Rating Raised to "Hold" at Wall Street Zen
Profil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Dr Reddy's Laboratories Ltd haqida
CEOErez Israeli
Xodimlar soni27,5 ming
Asos solingan1984
Bosh ofislarHaydarobod, Andhra Pradesh, Hindiston
Sektor-
Veb-saytdrreddys.com